葡萄糖醛酸化
戒毒(替代医学)
硫酸化
生物化学
胆酸
CYP8B1
化学
胆汁淤积
CYP3A4型
酶
药物代谢
胆汁酸
新陈代谢
细胞色素P450
硫转移酶
UGT2B7型
微粒体
生物
胆固醇7α羟化酶
医学
内分泌学
病理
替代医学
作者
Vlasia Kastrinou Lampou,Birk Poller,Felix Huth,Audrey Fischer,Gerd A. Kullak‐Ublick,Michael Arand,Heiko S. Schadt,Gian Camenisch
标识
DOI:10.1016/j.tiv.2022.105533
摘要
Bile acid (BA) homeostasis is a complex and precisely regulated process to prevent impaired BA flow and the development of cholestasis. Several reactions, namely hydroxylation, glucuronidation and sulfation are involved in BA detoxification. In the present study, we employed a comprehensive approach to identify the key enzymes involved in BA metabolism using human recombinant enzymes, human liver microsomes (HLM) and human liver cytosol (HLC). We showed that CYP3A4 was a crucial step for the metabolism of several BAs and their taurine and glycine conjugated forms and quantitatively described their metabolites. Glucuronidation and sulfation were also identified as important drivers of the BA detoxification process in humans. Moreover, lithocholic acid (LCA), the most hydrophobic BA with the highest toxicity potential, was a substrate for all investigated processes, demonstrating the importance of hepatic metabolism for its clearance. Collectively, this study identified CYP3A4, UGT1A3, UGT2B7 and SULT2A1 as the major contributing (metabolic) processes in the BA detoxification network. Inhibition of these enzymes by drug candidates is therefore considered as a critical mechanism in the manifestation of drug-induced cholestasis in humans and should be addressed during the pre-clinical development.
科研通智能强力驱动
Strongly Powered by AbleSci AI